期刊文献+

腹腔镜辅助D2根治术治疗进展期胃癌安全性、有效性的Meta分析 被引量:2

Safety and Efficacy of Laparoscopy-assisted D2 Radical Gastrectomy in Treatment of Advanced Gastric Cancer:A Meta-analysis
下载PDF
导出
摘要 目的系统分析腹腔镜辅助D2根治术治疗进展期胃癌的安全性和有效性。方法计算机检索Cochrane图书馆、PubMed、EMBase、CNKI数据库中有关腹腔镜辅助D2根治术与开腹D2根治术治疗进展期胃癌的前瞻性随机对照试验,检索时限为建库至2019年9月。由2名研究者独立提取纳入研究的试验设计、研究对象的特征、研究结果等,并采用RevMan 5.3软件进行Meta分析。结果按照入选标准有5项临床试验纳入研究,共2917例患者,其中腔镜组1463例、开腹组1454例。腔镜组手术时间长于开腹组(MD=31.46,95%CI 26.37~36.56,P<0.00001),术中出血量明显少于开腹组(MD=-15.40,95%CI-24.50^-6.29,P=0.0009),腔镜组术后第一次肛门排气时间、第一次进食清流食时间早于开腹组(MD=-0.19,95%CI-0.29^-0.08,P=0.0008;MD=-0.85,95%CI-1.05^-0.65,P<0.00001),住院时间短于开腹组(MD=-0.72,95%CI-1.19^-0.25,P=0.003),总体并发症发生率低于开腹组(RR=0.77,95%CI 0.63~0.93,P=0.006)。腔镜组与开腹组肿瘤大小比较差异无统计学意义(MD=-0.07,95%CI-0.23~0.09,P=0.39)。腔镜组淋巴结清扫数目少于开腹组(SMD=-0.91,95%CI-1.78^-0.05,P=0.04),腔镜组近端切缘距离小于开腹组(SMD=-0.38,95%CI-0.58^-0.17,P=0.0003),腔镜组与开腹组远端切缘距离比较差异无统计学意义(SMD=-0.13,95%CI-0.34~0.08,P=0.22)。结论在胃肠中心由经验丰富的外科医师对进展期胃癌实施腹腔镜辅助D2根治术是安全、有效的。 Objective To systematically analyze the safety and efficacy of laparoscopy-assisted D2 radical gastrectomy for advanced gastric cancer.Methods Cochrane library,PubMed,EMBase and CNKI were searched for prospective randomized controlled trials of laparoscopy-assisted versus open D2 radical gastrectomy for advanced gastric cancer.The search time limit was from the database establishment to Sep.2019.Two authors cited the details about the designs of the trials,features of the participants and the outcomes from the included studies independently.The data were analyzed by RevMan 5.3 software.Results According to the selection criteria,5 clinical trials were included in the study,with a total of 2917 patients,including 1463 patients in the laparoscopy group and 1454 patients in the laparotomy group.The operation time of the laparoscopy group was longer than that of the laparotomy group(MD=31.46,95%CI 26.37-36.56,P<0.00001);the amount of intraoperative blood loss was significantly less than that of the laparotomy group(MD=-15.40,95%CI-24.50--6.29,P=0.0009);the time of the first anal exhaustion and the first clear liquid food in the laparoscopy group were earlier than that of the open group(MD=-0.19,95%CI-0.29--0.08,P=0.0008;MD=-0.85,95%CI-1.05--0.65,P<0.00001);the hospital stay was shorter than that of the laparotomy group(MD=-0.72,95%CI-1.19--0.25,P=0.003);the overall complication rate was lower than that of the open group(RR=0.77,95%CI 0.63-0.93,P=0.006).There was no significant difference in tumor size between the two groups(MD=-0.07,95%CI-0.23-0.09,P=0.39).The number of lymph node dissections in the laparoscopy group was less than that in the laparotomy group(SMD=-0.91,95%CI-1.78--0.05,P=0.04),and the distance of the proximal resection edge in the laparoscopy group was less than that in the laparotomy group(SMD=-0.38,95%CI-0.58--0.17,P=0.0003),while there was no significant difference in the distance of the distal resection edge between thetwo groups(SMD=-0.13,95%CI-0.34-0.08,P=0.22).Conclusion Laparoscopy-assisted D2 radical gastrectomy for advanced gastric cancer performed by experienced surgeons in the gastrointestinal center is safe and effective.
作者 王晔飞 路志宇 张凯 杜加录 连凌云 WANG Yefei;LU Zhiyu;ZHANG Kai;DU Jialu;LIAN Lingyun(Department of General Surgery,the First Hospital of Yulin,Yulin 719000,China)
出处 《医学综述》 2020年第24期4973-4981,4987,共10页 Medical Recapitulate
关键词 进展期胃癌 腹腔镜辅助远端胃切除 META分析 Advanced gastric cancer Laparoscopy-assisted distal gastrectomy Meta-analysis
  • 相关文献

参考文献8

二级参考文献36

  • 1Sasako M,Sano T,Yamanoto S. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer[J].New England Journal of Medicine,2008,(05):453-462.
  • 2Fujita J,Kurokawa Y,Sugimoto T. Survival benefit of bursectomy in patients with resectable gastric cancer:interim analysis results of a randomized controlled trial[J].Gastric Cancer:Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,2012,(01):42-48.
  • 3Cunningham D,Allum WH,Stenning SP. MAGIC Trial Participants.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer[J].New England Journal of Medicine,2006,(01):11-20.
  • 4Zhu GL,Sun Z,Wang ZN. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach[J].Journal of Surgical Oncology,2012,(08):786-792.
  • 5Sasako M,McCulloch P,Kinoshita T. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer[J].British Journal of Surgery,1995,(03):346-351.
  • 6Oh SJ,Hyung WJ,Li C. Yonsei Gastric Cancer Clinic.The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer[J].Journal of Surgical Oncology,2009,(05):275-280.
  • 7Cuschieri A,Weeden S,Fielding J. Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial.Surgical Cooperative Group[J].British Journal of Cancer,1999,(9-10):1522-1530.
  • 8Hartgrink HH,van de Velde C J,Putter H. Extended lymph node dissection for gastric cancer:who may benefit?Final results of the randomized Dutch gastric cancer group trial[J].Journal of Clinical Oncology,2004,(11):2069-2077.
  • 9Kosuga T,Ichikawa D,Okamoto K. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients:relative comparison of the benefits in subgroups of patients[J].Gastric Cancer:Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,2011,(02):172-177.
  • 10Imamura H,Kurokawa Y,Kawada J. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer:results of a randomized controlled trial[J].World Journal of Surgery,2011,(03):625-630.

共引文献507

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部